Ligand Pharmaceuticals
LGND
#3484
Rank
A$5.96 B
Marketcap
A$302.94
Share price
0.97%
Change (1 day)
66.45%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$93.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$8.39 Million a decrease over its 2023 earnings that were of A$97.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$93.08 M1008.88%
2024 A$8.39 M-91.37%
2023 A$97.25 M-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$25.52 M-97.97%
2019 A$1.25 B275.62%
2018 A$0.33 B237.48%
2017 A$99.29 M49.05%
2016 A$66.61 M55.41%
2015 A$42.86 M36.87%
2014 A$31.31 M29.59%
2013 A$24.16 M1309.35%
2012 A$1.71 M-43.97%
2011 A$3.06 M-113.19%
2010 -A$23.21 Million59.86%
2009 -A$14.52 Million-61.33%
2008 -A$37.54 Million-58.75%
2007 -A$91 Million20.52%
2006 -A$75.51 Million81.27%
2005 -A$41.66 Million
2003 -A$29 Million-20.6%
2002 -A$36.53 Million4.38%
2001 -A$34.99 Million-48.83%
2000 -A$68.38 Million-19.74%
1999 -A$85.19 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$46.43 Million-5.83%
1996 -A$49.3 Million136.23%
1995 -A$20.87 Million-33.97%
1994 -A$31.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.46 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$93.58 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.09 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$34.91 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.92 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$34.02 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.14 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.98 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA